Clinical epidemiology of ciprofloxacin-resistant Proteus mirabilis isolated from urine samples of hospitalised patients

Clin Microbiol Infect. 2007 Dec;13(12):1204-6. doi: 10.1111/j.1469-0691.2007.01826.x. Epub 2007 Sep 11.

Abstract

This study investigated the clinical characteristics of ciprofloxacin-resistant Proteus mirabilis isolates from urine samples associated with nosocomial infection or colonisation, and identified the risk-factors for ciprofloxacin resistance. Data for patients with ciprofloxacin-resistant P. mirabilis isolates (n=13) were compared with those for randomly selected patients with ciprofloxacin-susceptible P. mirabilis isolates (n=40) who were matched by temporal occurrence as control patients. The majority of ciprofloxacin-resistant P. mirabilis isolates were multiresistant, and ciprofloxacin resistance was associated significantly with previous use of fluoroquinolones and production of extended-spectrum beta-lactamases.

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Ciprofloxacin / pharmacology*
  • Cross Infection / epidemiology*
  • Cross Infection / microbiology
  • Drug Resistance, Bacterial*
  • Drug Resistance, Multiple, Bacterial
  • Humans
  • Proteus Infections / epidemiology*
  • Proteus Infections / microbiology
  • Proteus mirabilis / drug effects*
  • Proteus mirabilis / isolation & purification
  • Urinary Tract Infections / epidemiology*
  • Urinary Tract Infections / microbiology
  • Urine / microbiology
  • beta-Lactamases / biosynthesis

Substances

  • Anti-Bacterial Agents
  • Ciprofloxacin
  • beta-Lactamases